Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yanning Syrup is a Traditional Chinese Medicine (TCM) oral formulation primarily composed of extracts from *Lamiophlomis rotata* (Kudo), *Scutellaria barbata* (D. Don), and *Spirodela polyrhiza* (紫萍). It is traditionally utilized for its heat-clearing, detoxifying, and anti-inflammatory properties. In modern clinical research, it is being investigated as an adjuvant therapy to oseltamivir for managing gastrointestinal symptoms in pediatric patients with influenza. The syrup is hypothesized to work by modulating immune function, restoring gut microbiota balance, and reducing systemic inflammation, thereby accelerating the resolution of symptoms such as diarrhea, vomiting, and abdominal pain associated with viral infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yanning Syrup.